Ruilaipu (Hangzhou) Medical Technology Co., Ltd.
PrivateLast Round
Series B
Sep 26, 2024
Total Funding Raised
$14.4M
Company Overview
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a medical technology company that develops high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) detection systems and automated sample pretreatment platforms for clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Comparables
Compare Ruilaipu (Hangzhou) Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Reigncom Biotech Co., Ltd. | 89% | |
| Hangzhou Calibra Diagnostics Co., Ltd. | 87% | |
| Hangzhou Well-healthcare Technologies Co., Ltd. | 87% | |
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2024 | ||||
| Series A Extension | Feb 6, 2023 | ||||
| Series A Extension | Mar 31, 2022 | ||||
| Series A Extension | May 31, 2021 | ||||
| Series A | Dec 18, 2020 | ||||
Angel | Oct 1, 2019 |
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3H Health Investment | Series A Extension |
| Legend Capital | Series A Extension, Series A |
| Guangzhou Industrial Investment Holding Group | Series B |
| 辰德资本 | Series A Extension, Series B, Series A, Angel |
| Vinno Capital | Series B |
| Huagai Capital | Series A, Series A Extension |
| CPE | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 31, 2021
Led by 3H Health Investment with participation from Huagai Capital, Legend Capital, and 辰德资本.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s valuation, stock price, and market status.